Idiopathic Anemia of Aging (IAA)

Stopped early · Phase 2

Conditions studied: Anemia, Aging

In brief

The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.

Key facts

Study ID

NCT00104169

Run by

National Institute on Aging (NIA)

People needed

0

Starts

2004-08-01

Expected to finish

2007-05-01

Last updated by the study team

2008-08-29

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 70 years of age or older
• Diagnosed with anemia
• Hemoglobin level less than or equal to 11
• Able to perform most activities of daily living without restriction

You may not qualify if…

• History of serious heart, liver or kidney disease
• Cancer treated within the last year except for skin cancer (excluding melanoma)
• Problems with your immune system
• Received Epoetin Alfa within the last year

Where it is running

• Harbor Hospital — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.